Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: terazosin hydrochloride

« Back to Dashboard
Terazosin hydrochloride is the generic ingredient in two branded drugs marketed by Abbott, Apotex, Ivax Sub Teva Pharms, Jubilant Cadista, Mylan, Mylan Technologies, Ranbaxy Labs Ltd, Sandoz, and Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride.

Summary for Generic Name: terazosin hydrochloride

Tradenames:2
Patents:0
Applicants:9
NDAs:14
Drug Master File Entries: see list24
Therapeutic Class:Cardiovascular Agents
Genitourinary Agents

Clinical Trials for: terazosin hydrochloride

Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
Status: Completed Condition: Antidepressant Induced Excessive Sweating

A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
Status: Completed Condition: Ejaculation

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075667-003Jul 28, 2000DISCNNo<disabled><disabled>
Ivax Sub Teva Pharms
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
TABLET;ORAL074530-003Apr 21, 2000DISCNNo<disabled><disabled>
Apotex
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075498-004Apr 12, 2001RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: terazosin hydrochloride

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-002Aug 7, 19874,112,097<disabled>
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 19945,212,176<disabled>
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-001Aug 7, 19874,251,532<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc